Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00160186
Status:
COMPLETED
Last Update Posted:
2008-03-31
First Post:
2005-09-09
Brief Title:
Gastrectomy Study Study to Investigate the Effect of Creon 25000 Minimicrospheres on Body Mass Index BMI in Patients After Gastrectomy
Sponsor:
Solvay Pharmaceuticals
Organization:
Solvay Pharmaceuticals
Study Overview
Official Title:
Double-Blind Multicenter Randomized Placebo-Controlled Parallel-Group Study to Investigate the Effect of Creon 25000 Minimicrospheres on Body Mass Index BMI in Patients After Gastrectomy
Status:
COMPLETED
Status Verified Date:
2008-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to investigate BMI and the nutritional parameters of Creon pancreatin versus placebo after a total or subtotal gastrectomy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None